In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Hutchison China Meditech closes £37mm IPO on AIM

Executive Summary

Hutchison China Meditech Ltd. (Chi-Med), the holding company of a health care group based in China (but itself incorporated in the Cayman Islands), has gone public over the AIM. It sold 14.55mm ordinary shares at 275 pence, for net proceeds of £37mm ($68mm). The company is a division of diversified, Hong Kong-based Hutchison Whampoa Ltd.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies